The Japan Investor - your own weekly strategist, guiding you to profitable Japanese stocks The Japan Investor
User ID
Password
 
   
About The Japan InvestorThe Japan Investor FeaturesYour benefitsWhy JapanThe Japan Investor TestimonialsThe Japan Investor ArchiveFAQRecommended ReadingBecome an Affiliate with The Japan InvestorSubscribe to The Japan Investor NewslettersContact The Japan InvestorTJI Premium Contents


How to trade Japanese Shares?

KYODO NEWS SEARCH

   News Photo

TJI Market Newsletter // This Week's Summary //

*Please log in first to download a full copy (PDF) of the report including portfolio.
If you are not registered please subscribe to The Japan Investor and receive full access to The Japan Investor Market Newsletters and Premium Contents. Click here to Continue.

Fate of Japanese Stocks: In the Hands of Foreigners   

May 12, 2008
  • With foreign investors accounting for upwards of 60% of market trading value and over 30% of total stock ownership, it is not an exaggeration to say that the fate of Japanese stocks is in the hands of foreign institutional investors.
  • Yet management of most Japanese companies are at best ambivalent and at worst xenophobic about foreign investors, and are again increasing cross-holdings as well as introducing “poison pill” takeover defenses to protect against unwanted suitors.
  • To date, some 460 Japanese companies (some 12% of all listed companies) have introduced poison pill anti-takeover measures. Some 66 or 55% of these companies had ROE lower than the market average of 10%, while 24 had a PBR below break-up value.
  • Both foreign and domestic institutional investors have generally voted against such proposals, as well as against non-independent directors. The Japan Securities Investment Advisors Association found that its members voted against proposals in 48% of the companies in which they held stocks, which is up over 2-fold in the last four years. These domestic institutional investors also voted against 30% of the poison pill proposals.
  • However, in looking at the 100 or so larger companies that have introduced poison pills and which have continuously been quoted since May 2003, we found that this shareholder opposition has had little impact on the relative stock price performance of the group as a whole. Indeed, the group we tracked has outperformed the Topix since mid-June.
  • The out-performance of these stocks seems to reflect the same paradox that often afflicts SRI (socially responsible investment) funds. “Sin” stocks such as alcoholic beverages, tobacco, gambling/gaming or other segments subject to SRI screens often as not outperform SRI-compliant stocks.
  • The lesson here is that stock prices have no social or moral conscience, as was demonstrated by the infamous Baron Rothschild quote to “buy when there's blood in the streets, even if the blood is your own."

2008-05-12.gif


 

See previous summaries >



 

 
Subscribe today and you will get full access to TJI premium contents.

Join The Japan Investor Mailing List and receive weekly summaries of TJI market newsletter FREE!


Subscription expired? You can renew your account here.

Seeking Alpha Certified



©2003 - 2007 The Japan Investor "Japan views you can use to invest in Japan" terms of service | privacy policy
Developed by M-Design